Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 20964521)

1.

The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong.

Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, Shen AL, Ho A, Hung IF, Riley S, Ho LM, Lin CK, Tsang T, Lo SV, Lau YL, Leung GM, Cowling BJ, Malik Peiris JS.

Clin Infect Dis. 2010 Nov 15;51(10):1184-91. doi: 10.1086/656740.

2.

Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong.

Mak GC, Choy PW, Lee WY, Wong AH, Ng KC, Lim W.

J Med Virol. 2010 Nov;82(11):1809-15. doi: 10.1002/jmv.21895.

PMID:
20872705
3.

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, Zambon M.

Lancet. 2010 Mar 27;375(9720):1100-8. doi: 10.1016/S0140-6736(09)62126-7. Epub 2010 Jan 21.

PMID:
20096450
4.

Epidemiological characteristics of 2009 (H1N1) pandemic influenza based on paired sera from a longitudinal community cohort study.

Riley S, Kwok KO, Wu KM, Ning DY, Cowling BJ, Wu JT, Ho LM, Tsang T, Lo SV, Chu DK, Ma ES, Peiris JS.

PLoS Med. 2011 Jun;8(6):e1000442. doi: 10.1371/journal.pmed.1000442. Epub 2011 Jun 21.

5.

Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.

Hardelid P, Andrews NJ, Hoschler K, Stanford E, Baguelin M, Waight PA, Zambon M, Miller E.

Health Technol Assess. 2010 Dec;14(55):115-92. doi: 10.3310/hta14550-03.

6.

A serial cross-sectional serologic survey of 2009 Pandemic (H1N1) in Hong Kong: implications for future pandemic influenza surveillance.

Wu JT, Ma ES, Lee CK, Chu DK, Ho PL, Shen AL, Ho A, Hung IF, Riley S, Ho LM, Lin CK, Tsang T, Lo SV, Lau YL, Leung GM, Cowling BJ, Peiris JS.

Influenza Other Respir Viruses. 2011 May;5 Suppl 1:190-4. No abstract available.

PMID:
21761588
7.

The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong: accuracy amidst ambiguity.

Kok J, Dwyer DE.

Clin Infect Dis. 2011 Jul 1;53(1):100-1; author reply 101, 103. doi: 10.1093/cid/cir281. No abstract available.

8.

Seroprevalence of pandemic H1N1 antibody among health care workers in Hong Kong following receipt of monovalent 2009 H1N1 influenza vaccine.

Zhou Y, Ng DM, Seto WH, Ip DK, Kwok HK, Ma ES, Ng S, Lau LL, Peiris JS, Cowling BJ.

PLoS One. 2011;6(11):e27169. doi: 10.1371/journal.pone.0027169. Epub 2011 Nov 10.

9.

Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data.

Wu JT, Ho A, Ma ES, Lee CK, Chu DK, Ho PL, Hung IF, Ho LM, Lin CK, Tsang T, Lo SV, Lau YL, Leung GM, Cowling BJ, Peiris JS.

PLoS Med. 2011 Oct;8(10):e1001103. doi: 10.1371/journal.pmed.1001103. Epub 2011 Oct 4.

10.

Hospitalization risk of the 2009 H1N1 pandemic cases in Hong Kong.

Wang XL, Wong CM, Chan KH, Chan KP, Cao PH, Peiris JM, Yang L.

BMC Infect Dis. 2014 Jan 16;14:32. doi: 10.1186/1471-2334-14-32.

11.

IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United States.

Li ZN, Lin SC, Carney PJ, Li J, Liu F, Lu X, Liu M, Stevens J, Levine M, Katz JM, Hancock K.

Clin Vaccine Immunol. 2014 Aug;21(8):1054-60. doi: 10.1128/CVI.00129-14. Epub 2014 May 28.

12.

The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis.

Presanis AM, De Angelis D; New York City Swine Flu Investigation Team, Hagy A, Reed C, Riley S, Cooper BS, Finelli L, Biedrzycki P, Lipsitch M.

PLoS Med. 2009 Dec;6(12):e1000207. doi: 10.1371/journal.pmed.1000207. Epub 2009 Dec 8.

13.

Seroepidemiological study of pandemic influenza H1N1 following the 2009-2010 wave in Greece.

Maltezou HC, Katerelos P, Mavrouli M, Lourida A, Routsias JG, Spanakis N, Maragos A, Tedoma A, Bassiakos Y, Koratzanis G, Mantagos S, Metallidis S, Katragkou A, Nikolaidis P, Roilides E, Theodoridou M, Tsakris A.

Vaccine. 2011 Sep 2;29(38):6664-9. doi: 10.1016/j.vaccine.2011.06.098. Epub 2011 Jul 14.

PMID:
21762749
14.

Pre- and post-pandemic prevalence of antibodies to the 2009 pandemic influenza A (H1N1) virus in Austrian adults.

Poeppl W, Poeppl G, Hunger M, Tobudic S, Winkler H, Faas A, Mooseder G, Burgmann H.

J Med Virol. 2012 Sep;84(9):1331-4. doi: 10.1002/jmv.23337.

PMID:
22825809
15.

Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis.

Presanis AM, Pebody RG, Paterson BJ, Tom BD, Birrell PJ, Charlett A, Lipsitch M, De Angelis D.

BMJ. 2011 Sep 8;343:d5408. doi: 10.1136/bmj.d5408.

16.

Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, Chan T, Gentleman B, Purych D, Gardy J, Patrick DM, Brunham RC, De Serres G, Petric M.

J Infect Dis. 2011 Jan 15;203(2):158-67. doi: 10.1093/infdis/jiq039.

17.

Estimating the disease burden of 2009 pandemic influenza A(H1N1) from surveillance and household surveys in Greece.

Sypsa V, Bonovas S, Tsiodras S, Baka A, Efstathiou P, Malliori M, Panagiotopoulos T, Nikolakopoulos I, Hatzakis A.

PLoS One. 2011;6(6):e20593. doi: 10.1371/journal.pone.0020593. Epub 2011 Jun 9.

18.

Influenza A (H1N1) 2009 antibodies in residents of New South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter.

Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, Dwyer DE.

PLoS One. 2010 Sep 7;5(9):e12562. doi: 10.1371/journal.pone.0012562.

19.

Seroprevalence of antibody to pandemic influenza A (H1N1) 2009 among healthcare workers after the first wave in Hong Kong.

Zhou Y, Ng DM, Seto WH, Ip DK, Kwok HK, Ma ES, Ng S, Lau LL, Wu JT, Peiris JS, Cowling BJ.

J Hosp Infect. 2011 Aug;78(4):308-11. doi: 10.1016/j.jhin.2011.02.017. Epub 2011 Apr 17.

PMID:
21501896
20.

Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population.

Chi CY, Liu CC, Lin CC, Wang HC, Cheng YT, Chang CM, Wang JR.

Clin Vaccine Immunol. 2010 Dec;17(12):1958-62. doi: 10.1128/CVI.00212-10. Epub 2010 Sep 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk